@NiranjanJS at #EAU23 presenting long term data on lymphovascular invasion as a prognostic marker for post prostatectomy oncological outcomes. Presence of LVI can improve patient counselling and inform treatment intensification. 💪🏼 work representing @USANZUrology & @VCCCAlliance
Lutectomy hits the big stage! Congrats @RenuEapen on the practice changing plenary #EAU23. Another feather in the hat for the high impact @pros_tic team and @gu_onc! Looking forward to further follow up and translational studies.
Thank you @declangmurphy and @RenuEapen! It was great fun contributing to a compelling @gu_onc discussion on the promise and perils of ChatGPT. It will be fascinating to see the urology community’s response to this disruptive technology! https://t.co/mW9sUmBd5F
Beautiful day here in Hobart for the Tasmanian @USANZUrology meeting! Prof @lawrentshuck kicking things off with a tour de force on penile cancer, Nanoknife and the 3 ’E’s’ of care centralisation. @JiasianTeh@_SeanOng
The @Sachinpp_ fan club watching his presentation on the diagnosis and classification of radiation prostatitis. A pathology not previously described in the literature! Looking forward to tomorrow’s talk on management strategies! @UAA2022 @lawrentschuk@MarcDiocera@gu_onc@TheRMH
We are recruiting! Our very popular full-time unaccredited Urology Registrar position is available from Feb 2023 for one year. Superb GU Oncology team, huge research program, robotic surgery etc. Closing date for applications 21st Aug. Details here https://t.co/svTE4SEPX9
Marc presenting a total 57072kms and 43956 mins saved for our patients! Pre-operative education migrated to Telehealth. Huge impact for our rural and regional patients.#EAU22#EAUN22#urology#urologynurses@gu_onc@MarcDiocera
Game Changer 3 at #eau22 – This morning @declangmurphy shared encouraging initial trial results for LuTectomy. Neoadjuvant Lu-PSMA is safe, effective and surgery is very straight forward.
@RenuEapen discussing the pros and cons of UroLift for BPO @EAU22. Immediate results, no retrograde ejaculation. Patient selection, implant placement and cystoscopy key to satisfaction! @gu_onc@PeterMacCC
@declangmurphy presenting initial results of the #Lutectomy trial at the #EAU22 main stage. Neoadjuvant Lu-PSMA is safe, effective and does not affect surgical difficulty. Excited for full study results at #EAU23! More discussion in an upcoming episode of https://t.co/KG5mCLOrR4
@veerukasi accepting the Crystal Matula Award - the EAU’s highest honour for contributions as a young urologist! Its been an honour to call you a mentor, colleague and friend @gu_onc. Work hard, dream big, change practice! #EAU22@PeterMacCC@BURSTurology
@veerukasi delivering an update on the MIMIC study. Check out the MIMIC Calculator for Predicting Spontaneous
Stone Passage available online! An excellent example of international collaboration lead bu @BURSTurology and @AusYURO!
@lawrentschuk on the 3 E’s of centralisation @USANZUrology#USANZ22. Collecting robust data remains the key to guiding change and leading the charge for improved patient outcomes.
@NiranjanJS@declangmurphy Overwhelming consensus at #AUA2022 that virtual presentations are here to stay! Nice discussion on the responsibility of the presenter to maintain professionalism. Do urology units have a duty to provide AV equipment and training? @DrChenKenneth